<html>

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=Generator content="Microsoft Word 15 (filtered)">
<title>S2262</title>
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:"Albertus Extra Bold";
	panose-1:2 14 8 2 4 3 4 2 2 4;}
@font-face
	{font-family:Marlett;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
	{font-family:Times;
	panose-1:2 2 6 3 6 4 5 2 3 4;}
@font-face
	{font-family:Albertus;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Segoe UI";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{margin:0in;
	margin-bottom:.0001pt;
	font-size:9.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.MsoDocumentMap, li.MsoDocumentMap, div.MsoDocumentMap
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	background:navy;
	font-size:12.0pt;
	font-family:"Tahoma",sans-serif;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{mso-style-link:"Balloon Text Char";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:9.0pt;
	font-family:"Segoe UI",sans-serif;
	letter-spacing:.2pt;}
p.FronterPage, li.FronterPage, div.FronterPage
	{mso-style-name:FronterPage;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
span.Para10pt
	{mso-style-name:Para10pt;
	font-family:"Times New Roman",serif;}
p.PrefileFronterTitle, li.PrefileFronterTitle, div.PrefileFronterTitle
	{mso-style-name:PrefileFronterTitle;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:17.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.StylePrefileFronterTitleLeft, li.StylePrefileFronterTitleLeft, div.StylePrefileFronterTitleLeft
	{mso-style-name:"Style PrefileFronterTitle + Left";
	margin-top:0in;
	margin-right:-.2in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	font-size:17.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.BillHead
	{mso-style-name:BillHead;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;
	font-weight:bold;}
span.BillHeading2
	{mso-style-name:BillHeading2;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;
	font-weight:bold;}
span.BillLanguage
	{mso-style-name:BillLanguage;
	font-family:"Times New Roman",serif;
	font-style:italic;}
p.HangingAnAct, li.HangingAnAct, div.HangingAnAct
	{mso-style-name:HangingAnAct;
	mso-style-link:"HangingAnAct Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.HangingAnActChar
	{mso-style-name:"HangingAnAct Char";
	mso-style-link:HangingAnAct;
	letter-spacing:.2pt;}
span.11ptChar
	{mso-style-name:11ptChar;
	font-family:"Times New Roman",serif;}
span.BillHeadUnBold
	{mso-style-name:BillHeadUnBold;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;}
p.bpuBill, li.bpuBill, div.bpuBill
	{mso-style-name:bpuBill;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:26.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuHeadSpon, li.bpuHeadSpon, div.bpuHeadSpon
	{mso-style-name:bpuHeadSpon;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
span.bpuHeadSponChar
	{mso-style-name:bpuHeadSponChar;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuIntro, li.bpuIntro, div.bpuIntro
	{mso-style-name:bpuIntro;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.bpuLegislature, li.bpuLegislature, div.bpuLegislature
	{mso-style-name:bpuLegislature;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:24.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuNormText, li.bpuNormText, div.bpuNormText
	{mso-style-name:bpuNormText;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.bpuReprint, li.bpuReprint, div.bpuReprint
	{mso-style-name:bpuReprint;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:22.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.bpuSponsor, li.bpuSponsor, div.bpuSponsor
	{mso-style-name:bpuSponsor;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuState, li.bpuState, div.bpuState
	{mso-style-name:bpuState;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:32.0pt;
	font-family:"Arial",sans-serif;
	font-weight:bold;}
span.charMarlett
	{mso-style-name:charMarlett;
	font-family:Marlett;}
p.ElevenPt, li.ElevenPt, div.ElevenPt
	{mso-style-name:ElevenPt;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPage12pt, li.FronterPage12pt, div.FronterPage12pt
	{mso-style-name:FronterPage12pt;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPageBillHeading, li.FronterPageBillHeading, div.FronterPageBillHeading
	{mso-style-name:FronterPageBillHeading;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;}
p.FronterPageNOCAPS, li.FronterPageNOCAPS, div.FronterPageNOCAPS
	{mso-style-name:FronterPageNOCAPS;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	font-size:12.0pt;
	font-family:"Times",serif;}
p.FronterPageTBox2, li.FronterPageTBox2, div.FronterPageTBox2
	{mso-style-name:FronterPageTBox2;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPageTextBox, li.FronterPageTextBox, div.FronterPageTextBox
	{mso-style-name:FronterPageTextBox;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.FronterSameAs, li.FronterSameAs, div.FronterSameAs
	{mso-style-name:FronterSameAs;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.Pg2Footer, li.Pg2Footer, div.Pg2Footer
	{mso-style-name:Pg2Footer;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:8.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
span.Style10pt
	{mso-style-name:"Style 10 pt";
	font-family:"Times New Roman",serif;}
p.StyleFronterPage11pt, li.StyleFronterPage11pt, div.StyleFronterPage11pt
	{mso-style-name:"Style FronterPage + 11 pt";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.StyleFronterPageLoweredby3pt, li.StyleFronterPageLoweredby3pt, div.StyleFronterPageLoweredby3pt
	{mso-style-name:"Style FronterPage + Lowered by  3 pt";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	position:relative;
	top:3.0pt;}
p.StyleFronterSameAsPatternSolid100White, li.StyleFronterSameAsPatternSolid100White, div.StyleFronterSameAsPatternSolid100White
	{mso-style-name:"Style FronterSameAs + Pattern\: Solid \(100%\) \(White\)";
	margin:0in;
	margin-bottom:.0001pt;
	background:white;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.Style1, li.Style1, div.Style1
	{mso-style-name:Style1;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
span.Whereas
	{mso-style-name:Whereas;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;
	font-weight:bold;}
p.bpuWpGraphic, li.bpuWpGraphic, div.bpuWpGraphic
	{mso-style-name:bpuWpGraphic;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.LeftBrackt
	{mso-style-name:LeftBrackt;
	font-family:"Albertus Extra Bold",sans-serif;
	font-weight:bold;}
span.RightBrackt
	{mso-style-name:RightBrackt;
	font-family:"Albertus Extra Bold",sans-serif;
	font-weight:bold;}
span.Superscript
	{mso-style-name:Superscript;
	font-family:"Albertus",sans-serif;
	font-weight:bold;
	vertical-align:super;}
p.sponUdate, li.sponUdate, div.sponUdate
	{mso-style-name:sponUdate;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
span.BoldItal
	{mso-style-name:BoldItal;
	font-weight:bold;
	font-style:italic;}
p.amendfooter, li.amendfooter, div.amendfooter
	{mso-style-name:amendfooter;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:9.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.HangingSup, li.HangingSup, div.HangingSup
	{mso-style-name:HangingSup;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.HangingTableBottom, li.HangingTableBottom, div.HangingTableBottom
	{mso-style-name:HangingTableBottom;
	margin-top:0in;
	margin-right:1.0in;
	margin-bottom:0in;
	margin-left:.8in;
	margin-bottom:.0001pt;
	text-indent:-.8in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.HangingTableTop, li.HangingTableTop, div.HangingTableTop
	{mso-style-name:HangingTableTop;
	margin-top:0in;
	margin-right:.5in;
	margin-bottom:0in;
	margin-left:.8in;
	margin-bottom:.0001pt;
	text-indent:-.8in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.BalloonTextChar
	{mso-style-name:"Balloon Text Char";
	mso-style-link:"Balloon Text";
	font-family:"Segoe UI",sans-serif;
	letter-spacing:.2pt;}
.MsoChpDefault
	{font-size:10.0pt;}
 /* Page Definitions */
 @page WordSection1
	{size:8.5in 14.0in;
	margin:1.5in 1.0in 1.0in 1.0in;}
div.WordSection1
	{page:WordSection1;}
@page WordSection2
	{size:8.5in 14.0in;
	margin:1.5in 113.75pt 1.0in 113.75pt;}
div.WordSection2
	{page:WordSection2;}
@page WordSection3
	{size:8.5in 14.0in;
	margin:1.0in 1.75in 1.2in 2.0in;}
div.WordSection3
	{page:WordSection3;}
-->
</style>

</head>

<body lang=EN-US>

<div class=WordSection1>

<p class=bpuBill><a name=bpuFrontPg></a>SENATE, No. 2262 </p>

<p class=bpuWpGraphic></p>

<p class=bpuState>STATE OF NEW JERSEY</p>

<p class=bpuLegislature>221st LEGISLATURE</p>

<p class=bpuWpGraphic>  </p>

<p class=bpuIntro>PRE-FILED FOR INTRODUCTION IN THE 2024 SESSION</p>

<p class=bpuIntro>&nbsp;</p>

</div>

<span style='font-size:12.0pt;line-height:120%;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:auto'>
</span>

<div class=WordSection2>

<p class=bpuIntro>&nbsp;</p>

<p class=bpuSponsor>Sponsored by:</p>

<p class=bpuSponsor>Senator  NICHOLAS P. SCUTARI</p>

<p class=bpuSponsor>District 22 (Somerset and Union)</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>SYNOPSIS</p>

<p class=bpuNormText>     Requires county health departments to maintain
reserve stock of opioid antidotes to dispense to certain entities on interim
basis to ensure uninterrupted supply. </p>

<p class=bpuNormText>&nbsp;</p>

<p class=bpuSponsor>CURRENT VERSION OF TEXT </p>

<p class=bpuNormText>     Introduced Pending Technical Review by Legislative
Counsel.</p>

<p class=bpuNormText>   </p>

</div>

<span style='font-size:10.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<div class=WordSection3>

<p class=HangingAnAct style='line-height:150%'><span class=BillHead>An Act</span><span
class=HangingAnActChar> </span>concerning overdose prevention and opioid
antidote availability, and amending P.L.2013, c.46.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     <span class=BillHeading2>Be It
Enacted </span><span class=BillLanguage>by the Senate and General Assembly of
the State of New Jersey:</span></p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     1.    Section 3 of P.L.2013,
c.46 (C.24:6J-3) is amended to read as follows:</p>

<p class=MsoNormal style='line-height:150%'>     3.    As used in this act:</p>

<p class=MsoNormal style='line-height:150%'>     &quot;Commissioner&quot; means
the Commissioner of Human Services.</p>

<p class=MsoNormal style='line-height:150%'>     <u>County health department
means the agency that has been established and organized in each county,
pursuant to section 6 of the Local Health Services Act, P.L.1975, c.329
(C.26:3A2-6), for the purpose of providing health services that are required to
protect the health of citizens within its area of jurisdiction.</u></p>

<p class=MsoNormal style='line-height:150%'>     &quot;Drug overdose&quot;
means an acute condition including, but not limited to, physical illness, coma,
mania, hysteria, or death resulting from the consumption or use of a controlled
dangerous substance or another substance with which a controlled dangerous
substance was combined and that a layperson would reasonably believe to require
medical assistance. </p>

<p class=MsoNormal style='line-height:150%'>     &quot;Emergency medical
response entity&quot; means an organization, company, governmental entity,
community-based program, or healthcare system that provides pre-hospital
emergency medical services and assistance to opioid or heroin addicts or
abusers in the event of an overdose.  &quot;Emergency medical response
entity&quot; includes, but is not limited to, a first aid, rescue and ambulance
squad or other basic life support (BLS) ambulance provider; a mobile intensive
care provider or other advanced life support (ALS) ambulance provider; an air
medical service provider; or a fire-fighting company or organization, which
squad, provider, company, or organization is qualified to send paid or
volunteer emergency medical responders to the scene of an emergency.</p>

<p class=MsoNormal style='line-height:150%'>     &quot;Emergency medical
responder&quot; means a person, other than a health care practitioner, who is
employed on a paid or volunteer basis in the area of emergency response, including,
but not limited to, an emergency medical technician, a mobile intensive care
paramedic, or a fire fighter, acting in that person's professional capacity.</p>

<p class=MsoNormal style='line-height:150%'>     <u>First responder means a
law enforcement officer, paid or volunteer firefighter, emergency medical
responder, or any other individual who, in the course of that individuals
employment, is dispatched to the scene of an emergency for the purpose of
providing medical care or other assistance.</u></p>

<p class=MsoNormal style='line-height:150%'>     <u>First response entity
means an organization, company, governmental entity, community-based agency or
program, or other organized group that employs two or more first responders,
whether on a paid or volunteer basis, for dispatch to emergency scenes.</u></p>

<p class=MsoNormal style='line-height:150%'>     &quot;Health care
practitioner&quot; means a prescriber, pharmacist, or other individual whose
professional practice is regulated pursuant to Title 45 of the Revised
Statutes, and who, in accordance with the practitioner's scope of professional
practice, prescribes or dispenses an opioid antidote.</p>

<p class=MsoNormal style='line-height:150%'>     &quot;Medical assistance&quot;
means professional medical services that are provided to a person experiencing
a drug overdose by a health care practitioner, acting within the practitioner's
scope of professional practice, including professional medical services that
are mobilized through telephone contact with the 911 telephone emergency
service.</p>

<p class=MsoNormal style='line-height:150%'>     &quot;Opioid antidote&quot;
means any drug, regardless of dosage amount or method of administration, which
has been approved by the United States Food and Drug Administration (FDA) for
the treatment of an opioid overdose.  &quot;Opioid antidote includes, but is
not limited to, naloxone hydrochloride, in any dosage amount, which is
administered through nasal spray or any other FDA-approved means or methods.</p>

<p class=MsoNormal style='line-height:150%'>     &quot;Patient&quot; means a
person who is at risk of an opioid overdose or a person who is not at risk of
an opioid overdose who, in the person's individual capacity, obtains an opioid
antidote from a health care practitioner, professional, or professional entity
for the purpose of administering that antidote to another person in an
emergency, in accordance with subsection c. of section 4 of P.L.2013, c.46
(C.24:6J-4).  &quot;Patient&quot; includes a professional who is acting in that
professional's individual capacity, but does not include a professional who is
acting in a professional capacity.</p>

<p class=MsoNormal style='line-height:150%'>     &quot;Prescriber&quot; means a
health care practitioner authorized by law to prescribe medications who, acting
within the practitioner's scope of professional practice, prescribes an opioid
antidote.  &quot;Prescriber&quot; includes, but is not limited to, a physician,
physician assistant, or advanced practice nurse.</p>

<p class=MsoNormal style='line-height:150%'>     &quot;Professional&quot; means
a person, other than a health care practitioner, who is employed on a paid
basis or is engaged on a volunteer basis in the areas of substance abuse
treatment or therapy, criminal justice, or a related area, and who, acting in
that person's professional or volunteer capacity, obtains an opioid antidote
from a health care practitioner for the purposes of dispensing or administering
that antidote to other parties in the course of business or volunteer
activities.  &quot;Professional&quot; includes, but is not limited to, a
sterile syringe access program employee, or a law enforcement official. </p>

<p class=MsoNormal style='line-height:150%'>     &quot;Professional
entity&quot; means an organization, company, governmental entity,
community-based program, sterile syringe access program, or any other organized
group that employs two or more professionals who engage, during the regular
course of business or volunteer activities, in direct interactions with opioid
or heroin addicts or abusers or other persons susceptible to opioid overdose,
or with other persons who are in a position to provide direct medical
assistance to opioid or heroin addicts or abusers in the event of an overdose. </p>

<p class=MsoNormal style='line-height:150%'>     &quot;Recipient&quot; means a
patient, professional, professional entity, emergency medical responder,
emergency medical response entity, school, school district, or school nurse who
is prescribed or dispensed an opioid antidote in accordance with section 4 of
P.L.2013, c.46 (C.24:6J-4).</p>

<p class=MsoNormal style='line-height:150%'>     <u>School means a public or
private school that has adopted a policy that complies with the requirements of
P.L.2013, c.46 (C.24:6J-1 et al.) authorizing the school to acquire and store
an opioid antidote and the school nurse or another designated individual to
administer the opioid antidote to an overdose victim in an emergency.</u></p>

<p class=MsoNormal style='line-height:150%'>(cf: P.L.2018, c.106, s.7)</p>

<p class=MsoNormal style='line-height:150%'><u><span style='text-decoration:
 none'>&nbsp;</span></u></p>

<p class=MsoNormal style='line-height:150%'>     2.    Section 4 of P.L.2013,
c.46 (C.24:6J-4) is amended to read as follows:</p>

<p class=MsoNormal style='line-height:150%'>     4.    a.   (1) A prescriber or
other health care practitioner, as appropriate, may prescribe or dispense an
opioid antidote:</p>

<p class=MsoNormal style='line-height:150%'>     (a)   directly or through a
standing order, to any recipient who is deemed by the health care practitioner
to be capable of administering the opioid antidote to an overdose victim in an
emergency;</p>

<p class=MsoNormal style='line-height:150%'>     (b)   through a standing
order, to any professional or emergency medical responder who is not acting in
a professional or volunteer capacity for a professional entity<b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>,<b><span
style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b> or an
emergency medical response entity, but who is deemed by the health care
practitioner to be capable of administering opioid antidotes to overdose
victims, as part of the professional's regular course of business or volunteer
activities; </p>

<p class=MsoNormal style='line-height:150%'>     (c)   through a standing
order, to any professional who is not acting in a professional or volunteer
capacity for a professional entity, but who is deemed by the health care
practitioner to be capable of dispensing opioid antidotes to recipients, for
administration thereby, as part of the professional's regular course of
business or volunteer activities;</p>

<p class=MsoNormal style='line-height:150%'>     (d)   through a standing
order, to any professional entity or any emergency medical response entity,
which is deemed by the health care practitioner to employ professionals or
emergency medical responders, as appropriate, who are capable of administering
opioid antidotes to overdose victims as part of the entity's regular course of
business or volunteer activities;</p>

<p class=MsoNormal style='line-height:150%'>     (e)   through a standing
order, to any professional entity which is deemed by the health care
practitioner to employ professionals who are capable of dispensing opioid
antidotes to recipients, for administration thereby, as part of the entity's
regular course of business or volunteer activities;</p>

<p class=MsoNormal style='line-height:150%'>     (f)   through a standing
order, to a school, school district, or school nurse pursuant to the provisions
of section 2 of P.L.2018, c.106 (C.18A:40-12.24)<u>; or</u></p>

<p class=MsoNormal style='line-height:150%'>     <u>(g)   through a standing
order, to any county health department, for the purposes of storage and interim
dispensation thereby, as provided by subsection i. of this section</u>.</p>

<p class=MsoNormal style='line-height:150%'>     (2)   (a)  For the purposes of
this subsection, whenever the law expressly authorizes or requires a certain
type of professional or professional entity to obtain a standing order for
opioid antidotes pursuant to this section, such professional, or the
professionals employed or engaged by such professional entity, as the case may
be, shall be presumed by the prescribing or dispensing health care practitioner
to be capable of administering or dispensing the opioid antidote, consistent
with the express statutory requirement.</p>

<p class=MsoNormal style='line-height:150%'>     (b)   For the purposes of this
subsection, whenever the law expressly requires a certain type of emergency
medical responder or emergency medical response entity to obtain a standing
order for opioid antidotes pursuant to this section, such emergency medical
responder, or the emergency medical responders employed or engaged by such emergency
medical response entity, as the case may be, shall be presumed by the
prescribing or dispensing health care practitioner to be capable of
administering the opioid antidote, consistent with the express statutory
requirement.</p>

<p class=MsoNormal style='line-height:150%'>     (c)   For the purposes of this
subsection, whenever the law expressly authorizes or requires a school or
school district to obtain a standing order for opioid antidotes pursuant to
this section, the school nurses employed or engaged by the school or school
district shall be presumed by the prescribing or dispensing health care
practitioner to be capable of administering the opioid antidote, consistent
with the express statutory requirement.</p>

<p class=MsoNormal style='line-height:150%'>     (3)   (a)  Whenever a
prescriber or other health care practitioner prescribes or dispenses an opioid
antidote to a professional or professional entity pursuant to a standing order
issued under paragraph (1) of this subsection, the standing order shall specify
whether the professional or professional entity is authorized thereby to
directly administer the opioid antidote to overdose victims; to dispense the
opioid antidote to recipients, for their administration to third parties; or to
both administer and dispense the opioid antidote.  If a standing order does not
include a specification in this regard, it shall be deemed to authorize the
professional or professional entity only to administer the opioid antidote with
immunity, as provided by subsection c. of this section, and it shall not be
deemed to authorize the professional or professional entity to engage in the
further dispensing of the antidote to recipients, unless such authority has
been granted by law, as provided by subparagraph (b) of this paragraph. </p>

<p class=MsoNormal style='line-height:150%'>     (b)   Notwithstanding the
provisions of this paragraph to the contrary, if the law expressly authorizes
or requires a certain type of professional, professional entity, emergency
medical responder, emergency medical response entity, school, school district,
or school nurse to administer or dispense opioid antidotes pursuant to a
standing order issued hereunder, the standing order issued pursuant to this
section shall be deemed to grant the authority specified by the law, even if
such authority is not expressly indicated on the face of the standing order. </p>

<p class=MsoNormal style='line-height:150%'>     (4)   Any prescriber or other
health care practitioner who prescribes or dispenses an opioid antidote in good
faith, and in accordance with the provisions of this subsection, shall not, as
a result of the practitioner's acts or omissions, be subject to any criminal or
civil liability, or any professional disciplinary action under Title 45 of the
Revised Statutes for prescribing or dispensing an opioid antidote in accordance
with P.L.2013, c.46 (C.24:6J-1&nbsp;et&nbsp;seq.).</p>

<p class=MsoNormal style='line-height:150%'>     b.    (1)  Any professional or
professional entity that has obtained a standing order, pursuant to subsection
a. of this section, for the dispensing of opioid antidotes, may dispense an
opioid antidote to any recipient who is deemed by the professional or
professional entity to be capable of administering the opioid antidote to an
overdose victim in an emergency. </p>

<p class=MsoNormal style='line-height:150%'>     (2)   Any professional or
professional entity that dispenses an opioid antidote in accordance with
paragraph (1) of this subsection, in good faith, and pursuant to a standing
order issued under subsection a. of this section, shall not, as a result of any
acts or omissions, be subject to any criminal or civil liability or any
professional disciplinary action for dispensing an opioid antidote in
accordance with P.L.2013, c.46 (C.24:6J-1 et seq.).</p>

<p class=MsoNormal style='line-height:150%'>     c.     (1)   Any emergency
medical responder or emergency medical response entity that has obtained a
standing order, pursuant to subsection a. of this section, for the
administration of opioid antidotes, may administer an opioid antidote to
overdose victims.</p>

<p class=MsoNormal style='line-height:150%'>     (2)   Any emergency medical
responder or emergency medical response entity that administers an opioid
antidote, in good faith, in accordance with paragraph (1) of this subsection,
and pursuant to a standing order issued under subsection a. of this section,
shall not, as a result of any acts or omissions, be subject to any criminal or
civil liability, or any disciplinary action, for administering the opioid
antidote in accordance with P.L.2013, c.46 (C.24:6J-1&nbsp;et&nbsp;seq.).</p>

<p class=MsoNormal style='line-height:150%'>     d.    (1)  Any person who is
the recipient of an opioid antidote, which has been prescribed or dispensed for
administration purposes pursuant to subsection a. or b. of this section, and
who has received overdose prevention information pursuant to section 5 of P.L.2013,
c.46 (C.24:6J-5), may administer the opioid antidote to another person in an
emergency, without fee, if the antidote recipient believes, in good faith, that
the other person is experiencing an opioid overdose.  </p>

<p class=MsoNormal style='line-height:150%'>     (2)   Any person who
administers an opioid antidote pursuant to paragraph (1) of this subsection
shall not, as a result of the person's acts or omissions, be subject to any
criminal or civil liability for administering the opioid antidote in accordance
with P.L.2013, c.46 (C.24:6J-1 et seq.). </p>

<p class=MsoNormal style='line-height:150%'>     e.     In addition to the
immunity that is provided by this section for authorized persons who are
engaged in the prescribing, dispensing, or administering of an opioid antidote,
the immunity provided by section 7 or section 8 of P.L.2013, c.46 (C.2C:35-30 or
C.2C:35-31) shall apply to a person who acts in accordance with this section,
provided that the requirements of those sections, as applicable, have been met.</p>

<p class=MsoNormal style='line-height:150%'>     f.     Any school, school
district, school nurse, school employee, or any other officer or agent of a
board of education, charter school, or nonpublic school who administers, or
permits the administration of, an opioid antidote in good faith in accordance
with the provisions of section 2 of P.L.2018, c.106 (C.18A:40-12.24), and
pursuant to a standing order issued under subsection a. of this section, shall
not, as a result of any acts or omissions, be subject to any criminal or civil
liability, or any disciplinary action, for administering, or for permitting the
administration of, the opioid antidote in accordance with P.L.2013, c.46
(C.24:6J-1 et seq.).</p>

<p class=MsoNormal style='line-height:150%'>     g.    Notwithstanding the
provisions of any law, rule, regulation, ordinance, or institutional or
organizational directive to the contrary, any person or entity authorized to
administer an opioid antidote pursuant to this section, may administer to an
overdose victim, with full immunity:</p>

<p class=MsoNormal style='line-height:150%'>     (1)   a single dose of any
type of opioid antidote that has been approved by the United States Food and
Drug Administration for use in the treatment of opioid overdoses; and</p>

<p class=MsoNormal style='line-height:150%'>     (2)   up to three doses of an
opioid antidote that is administered through an intranasal application, or
through an intramuscular auto-injector, as may be necessary to revive the
overdose victim.  Prior consultation with, or approval by, a third-party physician
or other medical personnel shall not be required before an authorized person or
entity may administer up to three doses of an opioid antidote, as provided in
this paragraph, to the same overdose victim.</p>

<p class=MsoNormal style='line-height:150%'>     h.    No later than 45 days
after the effective date of P.L.2017, c.381 the Commissioner of Health shall
provide written notice to all emergency medical response entities affected by
subsection g. of this section notifying them of the provisions of subsection g.
of this section.</p>

<p class=MsoNormal style='line-height:150%'>     <u>i.     (1)  Each county
health department shall obtain, through a standing order, and shall maintain in
an accessible storage location, a reserve stock of opioid antidotes sufficient
to ensure an uninterrupted supply of opioid antidotes is available to first
responders, first response entities, schools, and hospital pharmacies operating
in the county.  The quantity of opioid antidotes that are to be kept in reserve
stock by each county health department pursuant to this subsection shall be
determined by the director of the county health department, in consultation
with the county prosecutor, the county association of police chiefs, and the
county association of fire chiefs, and with input from the hospitals, school
districts, schools, emergency medical responders, and emergency medical response
entities operating in the county.  </u></p>

<p class=MsoNormal style='line-height:150%'>     <u>(2)   In the event that a
first responder, first response entity, or school anticipates that it will
exhaust its<i> </i>supply of opioid antidotes</u> <u>before it will be able to
acquire an additional supply pursuant to a standing order issued under
subsection a. of this section, the first responder, first response entity, or
school may make a request to the county health department to provide the
requester with an interim supply of opioid antidotes from the reserve stock
that is maintained pursuant to this subsection.  Upon receipt of a request, the
county health department shall promptly deliver to the requester an interim
supply of opioid antidotes in a quantity sufficient to ensure that the</u> <u>requester
will have adequate stock to continue to administer or dispense opioid
antidotes, as appropriate, during the interim period</u> <u>between the date
the requesters supply of opioid antidotes will be exhausted and the date the
requester will receive a new stock of opioid antidotes pursuant to the standing
order.</u></p>

<p class=MsoNormal style='line-height:150%'>     <u>(3)   In the event that a
hospital pharmacy anticipates that it will exhaust its available supply of
opioid antidotes before it is able to acquire an additional supply, and will
consequently be unable to meet the anticipated demand for opioid antidotes to
be dispensed pursuant to subsection a. of this section, the hospital pharmacy
may make a request to the county health department to provide the pharmacy with
an interim supply of opioid antidotes from the reserve stock that is maintained
pursuant to this subsection.  Upon receipt of a request, the county health
department shall promptly deliver to the hospital pharmacy an interim supply of
opioid antidotes in a quantity sufficient to ensure that the hospital pharmacy
will have adequate stock to continue to dispense opioid antidotes pursuant to
subsection a. of this section during the interim period between the date the
pharmacys supply of opioid antidotes will be exhausted and the date the
pharmacy will receive a new stock of opioid antidotes.</u></p>

<p class=MsoNormal style='line-height:150%'>     <u>(4)   Any first responder,
first response entity, school, or hospital pharmacy that obtains an interim
supply of opioid antidotes from the reserve stock maintained pursuant to this
subsection shall reimburse the county health department for the departments
actual costs to acquire and deliver the interim supply.</u></p>

<p class=MsoNormal style='line-height:150%'>     <u>(5)   County health
departments in the State may enter into shared service agreements, in
accordance with the Uniform Shared Services and Consolidation Act, sections 1
through 35 of P.L.2007, c.63 (C.40A:65-1 through C.40A:65-35), in order to
facilitate the acquisition of opioid antidotes at discounted rates, minimize
delivery costs, or otherwise facilitate the implementation of this subsection.</u></p>

<p class=MsoNormal style='line-height:150%'>     <u>(6)   The commissioner
shall establish rules and regulations, pursuant to the Administrative
Procedure Act, P.L.1968, c.410 (C.52:14B-1 et seq.), identifying: (a) the
manner and timeframe in which a first responder, first response entity, school,
or hospital pharmacy may make a request to a county health department for
interim opioid antidote supplies under this subsection; and (b) the manner and
timeframe in which a first responder, first response entity, school, or
hospital pharmacy shall provide reimbursement to the county health department for
the departments actual costs to acquire and deliver the interim supplies.  </u></p>

<p class=MsoNormal style='line-height:150%'>     <u>(7)   Any county health
department or employee of a county health department that provides a first
responder, first response entity, school, or hospital pharmacy with an interim
supply of opioid antidotes from the reserve stock maintained pursuant to this
subsection shall not, as a result of any acts or omissions, be subject to any
criminal or civil liability, or any disciplinary action, for providing such
interim supply in accordance with this subsection.</u></p>

<p class=MsoNormal style='line-height:150%'>(cf: P.L.2018, c.106, s.8)</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     3.    This act shall take
effect immediately.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal align=center style='text-align:center;line-height:150%'>STATEMENT</p>

<p class=MsoNormal align=center style='text-align:center;line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     This bill amends the Overdose
Prevention Act, P.L.2013, c.42 (C.24:6J-1 et seq.), to require each county
health department to obtain, and to maintain in an accessible storage location,
a reserve stock of opioid antidotes to be dispensed to first responders,
schools that have adopted a policy to acquire and administer opioid antidotes,
and hospital pharmacies, to ensure an uninterrupted supply of antidotes is
available to those entities.  The exact quantity of opioid antidotes to be
maintained in the reserve stock will be determined by the director of each
county health department in consultation with the county prosecutor, the county
association of police chiefs, and the county association of fire chiefs, and
with input from the hospitals, school districts, schools, emergency medical
responders, and emergency medical response entities operating in that county.  </p>

<p class=MsoNormal style='line-height:150%'>     The bill specifies that,
whenever a first responder, first response entity, school, or hospital pharmacy
anticipates it will exhaust its supply of opioid antidotes before it is able to
acquire more, it may make a request to the county health department to provide
an interim supply of opioid antidotes from the reserve stock.  Upon receiving a
request, the county health department will be required to promptly deliver to
the requester an interim supply sufficient to meet the requesters need for
opioid antidotes for the interim period between the date the requesters supply
will be exhausted and the date the requester will receive a new supply of
opioid antidotes by regular means.</p>

<p class=MsoNormal style='line-height:150%'>     First responders, first
response entities, schools, and hospital pharmacies that obtain an interim
supply of opioid antidotes from the reserve stock will be required to reimburse
the county health department for the departments actual costs in acquiring and
delivering the interim supply.  The bill expressly authorizes county health
departments to enter into shared service agreements, in accordance with the
Uniform Shared Services and Consolidation Act, in order to facilitate the
acquisition of opioid antidotes at discounted rates, minimize delivery costs,
or otherwise facilitate the implementation of the bills provisions.<u>  </u></p>

<p class=MsoNormal style='line-height:150%'>     The bill requires the
Commissioner of Human Services to establish rules and regulations to identify
the manner and timeframe to request a county health department provide interim supplies
of opioid antidotes, and the manner and timeframe to provide reimbursements to
the department for the costs of acquiring and delivering interim supplies.</p>

<p class=MsoNormal style='line-height:150%'>     Finally, the bill specifies
that any county health department or employee of a county health department
that provides an interim supply of opioid antidotes from its reserve stock will
be immune from criminal or civil liability, or any disciplinary action, in
association with the provision of the interim supply. </p>

</div>

</body>

</html>
